Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis: prevention and prophylaxis.

R L Carithers, C G Mayhall

    Virginia Medical
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis A is rare and usually not fatal, unlike Hepatitis B and non-A, non-B hepatitis, which can be chronic or fatal. Differentiating viral hepatitis types requires serologic testing, not clinical diagnosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

    Alimentary pharmacology & therapeutics·2007
    Same author

    Ventilator-associated pneumonia or not? Contemporary diagnosis.

    Emerging infectious diseases·2001
    Same author

    Cholestasis and alcoholic liver disease.

    Clinics in liver disease·2001
    Same author

    Hepatitis C in clinical practice.

    Journal of internal medicine·2001
    Same author

    Comparison of three methods to recover vancomycin-resistant enterococci (VRE) from perianal and environmental samples collected during a hospital outbreak of VRE.

    Infection control and hospital epidemiology·2001
    Same author

    Clinical infection control in gene therapy: a multidisciplinary conference.

    Infection control and hospital epidemiology·2000
    Same journal

    Branchial cysts presenting as neck infections.

    Virginia medical·1990
    Same journal

    20-year survival of von Hippel-Lindau hemangiomatosis: case report.

    Virginia medical·1990
    Same journal

    Legalizing drugs: a few simple questions.

    Virginia medical·1990
    Same journal

    The auxiliary and the teen-ager.

    Virginia medical·1990
    Same journal

    No dumping allowed. New rules for patient transfer.

    Virginia medical·1990
    Same journal

    Reforming the tort. Injured Infant Act changes; Bulala case and the cap.

    Virginia medical·1990
    See all related articles

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Virology

    Background:

    • Hepatitis A, B, and non-A, non-B represent significant causes of sporadic hepatitis.
    • Understanding transmission routes and clinical outcomes is crucial for public health.
    • Distinguishing between hepatitis etiologies is essential for appropriate patient management.

    Observation:

    • Hepatitis A: Primarily fecal-oral transmission, rare fatalities, no chronic cases.
    • Hepatitis B: Diverse transmission routes, common fatalities, frequent chronic infections.
    • Non-A, non-B Hepatitis: Parenteral transmission, documented fatalities and chronic cases.

    Findings:

    • Hepatitis A accounts for 25% of sporadic hepatitis cases.
    • Hepatitis B causes 50% of sporadic hepatitis cases.

    Related Experiment Videos

  • Non-A, non-B hepatitis comprises 25% of sporadic hepatitis cases.

    • Implications:

    • Clinical presentation alone is insufficient for diagnosing viral hepatitis etiology.
    • Serologic testing is imperative for accurate etiological diagnosis.
    • Distinct epidemiological profiles necessitate targeted prevention and treatment strategies for each hepatitis type.